PharmaFutures was set up in response to the serious challenges facing the pharmaceutical industry and, in particular, the dilemma of meeting short-term profitability for investors while meeting growing societal expectations of effective, affordable and accessible medicines. The aim of this project is to help investors and companies reconcile these competitive tensions to enable the industry to more systematically and strategically address these unmet societal needs.


This is such a vital industry, with a strong and complex social contract. Hopefully, PharmaFutures can contribute to improved communications and a better alignment between society and shareholder needs.

Sophia Tickell, Director of PharmaFutures